Research-use and clinical decision-support systems can use similar algorithms while carrying different expectations about intended use, evidence, controls, and users. A label does not make a model accurate or inaccurate by itself. It describes the context in which the system is presented and evaluated, and that context determines what evidence is relevant.
Start with intended use
A useful intended-use statement identifies the input, the output, the user, the setting, the target population, and the decision or workflow the output is meant to inform. Ambiguous wording makes it difficult to choose representative data or decide which errors matter. It also makes later changes harder to assess because the boundary of the system is unclear.
Research evaluation answers a narrower question
- Is the technical method feasible on a defined dataset and task?
- Which inputs, labels, preprocessing steps, and model versions were used?
- How were cases separated to reduce patient or specimen leakage?
- What failure modes and data gaps were visible in the study?
- Which findings are exploratory and require confirmation in another setting?
Research-use evidence can be valuable without being clinical evidence. It may show that a method is promising, reproducible under stated conditions, or worth testing further. It does not automatically establish performance in a routine laboratory, suitability for a medical purpose, or acceptability under a particular jurisdiction's device framework.
Clinical decision support adds context and control
For a system intended to inform clinical work, evaluation usually needs to connect technical performance with the intended users, environment, workflow, and risks. Relevant evidence can include external or local evaluation, characterization of inputs, calibration and uncertainty, usability, human-AI interaction, documentation, change control, and plans for monitoring. The exact obligations depend on the product, intended purpose, risk classification, and applicable rules.
A sound validation record explains how data represent the intended setting, how reference standards were established, how exclusions were handled, and how performance varies across relevant subgroups and conditions. It also records what the system does not cover. A strong result with an unrepresentative test set can answer the wrong question with high precision.
The practical distinction is therefore not research versus clinical as a claim about sophistication. It is the difference between evidence for a bounded research question and evidence for a defined use with corresponding safety, transparency, and lifecycle responsibilities. Clear scope makes both forms of work easier to interpret.
Sources
- Clinical Decision Support Software (U.S. Food and Drug Administration)
- Regulation EU 2017/746 on in vitro diagnostic medical devices (European Union)
- Good Machine Learning Practice for Medical Device Development: Guiding Principles (U.S. Food and Drug Administration)
Written by
Digital Pathology Solutions Editorial Team
Medical AI and digital pathology




